Chronic haloperidol or clozapine treatment does not alter parvalbumin immunoreactivity in the rat frontal cortex or hippocampus

Neuroscience Letters

Volumn 373, Issue 1, 2004, Pages 57-60

  Cahir, Marie ^a   Costello, Isabel ^a   King, David J ^a   Reynolds, Gavin P ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Calcium binding protein; Calretinin; Clozapine; Haloperidol; Parvalbumin

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; CALRETININ; CLOZAPINE; HALOPERIDOL; PARVALBUMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FRONTAL CORTEX; HIPPOCAMPUS; IMMUNOREACTIVITY; LONG TERM CARE; NONHUMAN; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA;

EID: 8844236950     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2004.09.057     Document Type: Article

References (19)

1. C.L. Beasley, and G.P. Reynolds Parvalbumin immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics Schizophr. Res. 24 1997 349 355
2. C.L. Beasley, Z.J. Zhang, I. Patten, and G.P. Reynolds Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium binding proteins Biol. Psychiatry 52 2002 708 715
3. F.M. Benes, and S. Berretta GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder Neuropsychopharmacology 25 2001 1 27
4. F.M. Benes, Y. Khan, S.L. Vincent, and R. Wickramasinghe Differences in the subregional and cellular distribution of GABA-A receptor binding in the hippocampal formation of schizophrenic brain Synapse 22 1996 338 349
5. F.M. Benes, and N. Lange Two-dimensional versus three-dimensional cell counting: a practical perspective Trends Neurosci. 24 2001 11 17
6. M. Cahir, T.D.W. Mawhinney, and D.J. King Differential region-specific regulation of central alpha1-adrenoceptor binding following chronic haloperidol and clozapine administration in the rat Psychopharmacology 172 2004 196 201
7. A. Carlsson, N. Waters, and M.L. Carlsson Neurotransmitter interactions in schizophrenia-therapeutic implications Biol. Psychiatry 46 1999 1388 1395
8. S.M. Cochrane, M. Kennedy, C.E. Mc Kerchar, L.J. Steward, J.A. Pratt, and B.J. Morris Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs Neuropsychopharmacology 28 2003 265 275
9. S. Colbach, and M.R. Celio Ontogeny of the calcium binding protein parvalbumin in the rat nervous system Anat. Embryol. 184 1991 103 124
10. D.W. Eyles, J.J. Mc Grath, and G.P. Reynolds Neuronal calcium binding proteins and schizophrenia Schizophr. Res. 57 2002 27 34
11. J.R.T. Greene, J.E. Kerkhoff, L. Guiver, and S. Totterdell Structural and functional abnormalities of the hippocampsl formation in rats with environmentally induced reductions in prepulse inhibition of acoustic startle Neuroscience 103 2001 315 323
12. P.J. Harrison The neuropathological effects of antipsychotic drugs Schizophr. Res. 40 1999 87 99
13. R.L. Jakab, and P.S. Goldman Rakic Segregation of serotonin 5HT2A and 5HT3 receptors in inhibitory circuits of the primate cortex J. Comp. Neurol. 417 2000 337 348
14. C. Konradi, and S. Heckers Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia Biol. Psychiatry 50 2001 729 742
15. G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, fourth ed., Academic Press, London.
16. G.P. Reynolds, and C.L. Beasley GABAergic neuronal subtypes in the human frontal cortex - development and deficits in schizophrenia J. Chem. Neuroanat. 22 2001 95 100
17. O. Shirakawa, and C.A. Tamminga Basal ganglia GABA-A and dopamine D1 binding site correlates of haloperidol induced oral dyskinesias in rat Exp. Neurol. 12 1994 62 69
18. F.I. Tarazi, W.J. Florijn, and I. Creese Differential regulation of dopamine receptors following chronic typical and atypical antipsychotic drug treatment Neuroscience 78 1997 985 996
19. Z.J. Zhang, and G.P. Reynolds A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia Schizophr. Res. 55 2002 1 10